Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblasts are key to wound healing by managing immune cells and forming scar tissue.

Biological therapy boosts the immune system to effectively fight melanoma.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

Pantethine may boost the immune system's ability to fight sarcoma.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Isoliensinine, a natural compound, prevents stress-related hair greying by blocking a specific receptor on hair cells.

MK-386 reduces sebum DHT levels.

Medications for PCOS don't seem to raise heart disease risk.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

SM04755 may be an effective topical treatment for psoriasis.

Finasteride effectively treats hair loss in transgender men with few side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Scientists found new, better-working inhibitors for a hormone-related enzyme.